Growth Metrics

Innoviva (INVA) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 343.48%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 343.48%
Dec 31, 2025 202.53%
Sep 30, 2025 181.07%
Jun 30, 2025 5.62%
Mar 31, 2025 49.07%
Dec 31, 2024 6.42%
Sep 30, 2024 50.69%
Jun 30, 2024 165.22%
Mar 31, 2024 80.00%
Dec 31, 2023 184.12%
Sep 30, 2023 118.79%
Jun 30, 2023 -8.52%
Mar 31, 2023 -5.76%
Dec 31, 2022 1,316.67%
Sep 30, 2022 1,000.00%
Jun 30, 2022 826.32%
Mar 31, 2022 695.83%
Dec 31, 2021 -57.14%
Sep 30, 2021 -54.55%
Jun 30, 2021 -48.65%
Mar 31, 2021 -42.86%
Dec 31, 2020 -15.15%
Sep 30, 2020 37.50%
Jun 30, 2020 -72.79%
Mar 31, 2020 -71.62%
Dec 31, 2019 -79.38%
Sep 30, 2019 -86.13%
Jun 30, 2019 -26.49%
Mar 31, 2019 -24.87%
Dec 31, 2018 -23.44%
Sep 30, 2018 -30.52%
Jun 30, 2018 -35.99%
Mar 31, 2018 -39.94%
Dec 31, 2017 -43.21%
Sep 30, 2017 -34.65%
Jun 30, 2017 66.09%
Mar 31, 2017 69.95%
Dec 31, 2016 66.52%
Sep 30, 2016 53.63%
Jun 30, 2016 -36.96%
Mar 31, 2016 -36.30%
Dec 31, 2015 -31.79%
Sep 30, 2015 287.50%
Mar 31, 2015 -96.89%
Dec 31, 2014 -96.84%
Sep 30, 2014 -99.25%
Mar 31, 2014 8.04%
Dec 31, 2013 11.84%
Sep 30, 2013 -10.61%
Jun 30, 2013 -7.33%
Mar 31, 2013 -10.43%
Dec 31, 2012 -11.74%
Sep 30, 2012 -6.14%
Jun 30, 2012 -6.52%
Dec 31, 2011 1.54%